TransCon hGH, an investigational GHD therapy administered once weekly

Our investigational growth hormone prodrug releases somatropin (rhGH or hGH) with once-weekly administration. Marketing applications have been submitted in the United States and Europe for pediatric growth hormone deficiency (GHD).

We are passionate about patients and science

We are a dynamic place to grow and learn with a unique global culture and entrepreneurial spirit.

You are about to access www.ascendispharma.us.
The information on this website is intended for residents of the United States. Click below to confirm you are a citizen and/or resident of the United States.